Similarly, the peptide A7R (ATWLPPR) specifically binds to NRP1, has anti-angiogenic activity in vitro by inhibiting NRP1/VEGFR2 signaling, and curbs tumor angiogenesis and tumor growth in vivo [174,368]. The gene discussed is NRP1; the disease is neoplasm.